Avanir Pharmaceuticals (AVNR) Reports In-Line Q2 EPS
Tweet Send to a FriendGet Alerts AVNR Hot Sheet
Price: $3.41 +0.29%
EPS Growth %: +25.0%
Financial Fact:
Interest income: 15.07K
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: +25.0%
Financial Fact:
Interest income: 15.07K
Today's EPS Names:
ANF, DXLG, FL, More
Trade AVNR Now!
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.29 million.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Gordmans Stores, Inc. (GMAN) Tops Q1 EPS Views; Issues Light Q2 Outlook
- Pandora Media (P) Reports In-Line Q1 EPS, Revenue & Guidance Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
